Literature DB >> 28198116

Periodic benefit-risk evaluation reports have substantial promise to guide patient care and should be made publicly available.

Michael Fralick1,2, Aaron S Kesselheim1.   

Abstract

Entities:  

Mesh:

Year:  2017        PMID: 28198116     DOI: 10.1002/pds.4177

Source DB:  PubMed          Journal:  Pharmacoepidemiol Drug Saf        ISSN: 1053-8569            Impact factor:   2.890


× No keyword cloud information.
  2 in total

1.  Use of Health Care Databases to Support Supplemental Indications of Approved Medications.

Authors:  Michael Fralick; Aaron S Kesselheim; Jerry Avorn; Sebastian Schneeweiss
Journal:  JAMA Intern Med       Date:  2018-01-01       Impact factor: 21.873

2.  Multi-Criteria Decision Analysis for Benefit-Risk Analysis by National Regulatory Authorities.

Authors:  Orin Chisholm; Patrick Sharry; Lawrence Phillips
Journal:  Front Med (Lausanne)       Date:  2022-01-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.